Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 180 M268 M178 M206 M 832 M Research & development ———— — Operating income 333 M260 M310 M401 M 1.3 B Non-Operating Income, Total -1 M4 M19 M1 M 23 M Interest expense, net of interest capitalized 8 M11 M11 M8 M 38 M Non-Operating Income, excl. Interest Expenses -3 M4 M19 M0 20 M Unusual income/expense 2 M001 M 3 M Pretax income 323 M254 M318 M394 M 1.29 B Equity in earnings -2 M-3 M4 M16 M 15 M Taxes 72 M62 M71 M78 M 283 M Non-controlling/minority interest 4 M04 M3 M 11 M After tax other income/expense ———— — Net income before discontinued operations 246 M188 M248 M327 M 1.01 B Discontinued operations 0000 — Net income 246 M188 M248 M327 M 1.01 B Dilution adjustment 0000 0 Preferred dividends 46 M-14 M5 M21 M 58 M Diluted net income available to common stockholders 200 M202 M243 M306 M 951 M Basic earnings per share (Basic EPS) 0.630.480.630.84 2.58 Diluted earnings per share (Diluted EPS) 0.620.480.630.83 2.56 Average basic shares outstanding 393.29 M393.11 M393.11 M392.04 M — Diluted shares outstanding 394.67 M393.75 M394.59 M392.7 M — EBITDA 594 M580 M561 M688 M 2.42 B EBIT 511 M498 M479 M603 M 2.09 B Cost of revenue 3.29 B3.29 B3.27 B3.62 B 13.47 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 83 M82 M82 M85 M 332 M